New York Medical College is a private biomedical health sciences university based in Valhalla, New York. Founded in 1860, it is a member of the Touro College and University System.

During the past decade, New York Medical College conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 107 clinical trials were completed, i.e. on average, 95.5% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 44 clinical trials were completed. i.e. 102.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Medical College" #1 sponsor was "Children's Oncology Group" with 118 trials, followed by "National Cancer Institute (NCI)" with 42 trials sponsored, "New York Medical College" with 30 trials sponsored, "Radiation Therapy Oncology Group" with 18 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 18 trials sponsored. Other sponsors include 142 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Medical College" #1 collaborator was "National Cancer Institute (NCI)" with 148 trials as a collaborator, "Children's Oncology Group" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Cystic Fibrosis Foundation" with 7 trials as a collaborator and "Medical College of Wisconsin" with 7 trials as a collaborator. Other collaborators include 124 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "New York Medical College" are "Leukemia" (21 trials), "Cystic Fibrosis" (19 trials), "Recurrent Neuroblastoma" (17 trials), "Lymphoma" (16 trials) and "Sarcoma" (14 trials). Many other conditions were trialed in "New York Medical College" in a lesser frequency.

Most popular intervention types in "New York Medical College" are "Drug" (299 trials), "Other" (99 trials), "Biological" (86 trials), "Procedure" (73 trials) and "Radiation" (72 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Cyclophosphamide" (39 trials), "Placebo" (32 trials), "cyclophosphamide" (32 trials) and "Vincristine Sulfate" (31 trials). Other intervention names were less common.

The vast majority of trials in "New York Medical College" are 345 trials for "All" genders, 11 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "New York Medical College". undefined are not yet recruiting, 59 are recruiting, 60 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 208 completed trials in New York Medical College, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in New York Medical College, 38 "Phase 1" clinical trials were conducted, 151 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 10 trials that are defined as “Not Applicable".

New York Medical College has several departments that took part in Clinical trials: "New York Medical College/Westchester Medical Center" - 27 trials, "Ny Cancer%" - 4 trials, "New York Medical College/Bradhurst Building" - 4 trials, "New York Medical College Division of Oncology" - 2 trials